Delivery Order SPE2DB22D1106-SPE2DB25FERN6

Award Date 6/3/25
Potential Completion Date 6/25/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order for $5,787.60 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of NEMLUVIO 30 MG PENS, a pharmaceutical product, with a completion date of June 13, 2025. The contract is a firm fixed price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,787.60 Firm Fixed Price delivery order is for the provision of "NEMLUVIO 30 MG PENS" and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.20 firm-fixed-price contract is for the delivery of NEMLUVIO 30 MG PENS, with a completion date of June 17, 2025. The contract is not a set-aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the company's larger $999,999,999.00...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6NKF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,858.40 firm fixed-price delivery order is for the supply of 4568201517 NEMLUVIO 30 MG PENS, a medical product. The contract has a period of performance through June 2, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,929.20, is for the delivery of the medication "NEMLUVIO 30 MG PENS". The contract is not set aside and is a firm fixed-price type. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of May 19, 2025. This delivery order...
This is a $40,628.97 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery...
This is a $54,074.37 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized medical supplies. The contract is not set aside and is awarded under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $541,330.31 contract has an ultimate completion date of December 20, 2024 and covers the delivery of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. Amerisourcebergen Drug Corp...
This is a $55,376.30 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a range of pharmaceutical products and medical supplies. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
This is a $33,204.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FERN6
    Delivery Order

This is a $3,858.40 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of NEMLUVIO 30 MG PENS medical products, with a period of performance through June 25, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned.

Generated 9/2/25, 9:57 AM